ReGen Factor

Bio Identical Fibroblast Growth Factors

 

Our Science

ReGen Factor has developed first to market technology to produce bio-identical and cost effective Fibroblast growth factors (FGFs)  which regulate a broad spectrum of biological functions, including cellular proliferation, survival, migration, and differentiation.

Pipeline and Clinical Trials

ReGen Factor aims to establish PepFactor Scalp as the world leading treatment for Adrogenous 

genetic Alopecia (AGA)  in both men and women.

Cosmetic trials commence in mid January 2021 and is set to complete on 28 April 2021.

About Adrogenous Alopecia

Prevalence of AGA is approximately 50% in the population. The prevalence increases with age. The grade of alopecia gradually increases from the earlier stages (I and II) to the more severe stages as age increases.

 

PepFactor Iaon

ReGen Factor has developed PepFactor Iaon cream for the  treatment of hard to heal diabetic ulcers and pressure wounds. Initial studies are promising with fast healing times for diabetic ulcers. See https://www.diabeticulserheal.com/ 

The global chronic wound care market size is projected to reach USD 16.36 billion by the end of 2027.

PepFactor Scalp &

PepFactor Skin

ReGen Factor aims to establish PepFactor Scalp as the world leading treatment for Adrogenous 

genetic Alopecia (AGA)  in both men and women.

PepFactor Skin offers disruptive treatments for anti-aging skin and acne treatments.

Media Centre

    ReGen Factor Announcements

Morning Paper